Approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk.

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.

Age-related hormone shifts can reduce bone mass and density, putting us at risk for osteoporosis (weak, brittle bones). Known as a “silent disease,” the condition often goes undetected until a bone ...

An illustration of osteoporosis. (Science Photo Library/Brand X Pictures/Getty Images) Research points to a key bone-strengthening mechanism at work in the body, which could be targeted to treat the ...

Osteoporosis is a silent condition that affects 10 million Americans, and 44 million have low bone density, yet 80% of older Americans who suffer bone breaks are not tested or treated for osteoporosis ...

Add Yahoo as a preferred source to see more of our stories on Google. Are you due for a bone density test? The U.S. Preventive Services Task Force announced updated osteoporosis screening guidelines ...

An AI tool could flag patients at risk for osteoporosis or osteopenia by evaluating standard hip and pelvis x-rays, new ...

If you think osteoporosis is something you don’t have to worry about until you’re older, think again. This serious bone disease is something women of all ages should be aware of and actively work to ...

The appetite-suppressing drugs decrease a person's intake of food and nutrients, which can impact bone health and lead to ...

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%. A related condition, osteomalacia, which involves the softening of the ...